← Evidence map

ReviewLung Cancer (Auckland, N.Z.)2015

AXL receptor tyrosine kinase as a therapeutic target in NSCLC.

Ross A Okimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

25 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 28210148